This is the title of my latest column Evidence base.
In this latest edition of Perspectives from the Healthcare Economist, Jason Shafrin (FTI Consulting and Mann School of Pharmacy, University of Southern California) examines how AI is beginning to reshape health economics and outcomes research (HEOR), from evidence generation and literature reviews to data analysis and payer decision making.. Ahead of ISPOR 2026 (May 17-20, 2026, Philadelphia) While AI and evidence generation are expected to feature prominently in discussions in the HEOR community, Shafrin explores whether AI is a threat to the profession or a catalyst for its growth. They argue that while AI will transform the way evidence is generated, accessed and interpreted, the need for strong HEOR expertise and high-quality evidence will remain central to health care decision making.
Click to read full article Here.
